This #WorldInclusionDay, and in honor of the launch of our Disability Inclusion Employee Resource Group, we’re passing the phone to our colleagues around the world who champion inclusion every day. From leading our ERGs to mentoring others, their dedication helps drive innovation and strengthens our diverse workforce. https://gilead.inc/3Yhyd2n #GileadLife #PassThePhoneChallenge
Gilead Sciences
Ricerca biotecnologica
Foster City, CA 648.113 follower
Creating Possible
Chi siamo
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
- Sito Web
-
http://www.gilead.com
Link esterno per Gilead Sciences
- Settore
- Ricerca biotecnologica
- Dimensioni dell’azienda
- Oltre 10.001 dipendenti
- Sede principale
- Foster City, CA
- Tipo
- Società quotata
- Data di fondazione
- 1987
Località
Dipendenti presso Gilead Sciences
Aggiornamenti
-
For the second year in a row, we’ve been recognized as one of America's Greenest Companies by Newsweek. Sustainability is embedded in everything we do, and we prioritize managing the way we use energy, water and materials to shape a more equitable future for all. #GileadForGood
-
We’re passionate about making a difference in the world and equally committed to celebrating the unique impact each person has in the communities we serve. This #HispanicHeritageMonth we honor teammates like Norma who contribute to cultivating a sense of inclusivity and belonging for our Hispanic colleagues, helping them bring their bold ideas and whole selves to work. #HHM2024 #GileadLife
-
#GileadNews: Today at #HIVR4P2024, we announced additional data from our second Phase 3 clinical trial of our investigational medication for #HIV prevention. These results help demonstrate the medication’s safety and efficacy profile in a broad range of cisgender men and gender-diverse individuals around the world who need or want PrEP. Read more: https://gilead.inc/47Xsty4
-
#GileadNews: We’ve signed non-exclusive, royalty-free voluntary licensing agreements to enable access to our investigational medication for #HIV prevention across 120 high-incidence, resource-limited countries, if approved. The agreements reflect our ongoing commitment to providing rapid, broad and sustainable access to our medicines and to improving health equity across the globe. Learn more: https://gilead.inc/3Bw8AlB
-
For more than 35 years, we’ve translated cutting-edge science into innovative solutions, advanced our commitment to achieve health equity and delivered life-changing medicines to people all over the world. Explore our newly redesigned website to see the strides we’ve made: https://www.gilead.com/ #GileadLife
Explore Our Newly Redesigned Website
-
“We’re less than six years away from the United Nations’ goal of eliminating HIV by 2030, yet no country in the world is close to that goal.” Authors of a new report, commissioned by Gilead, found that there are treatment and tools available to help end the HIV epidemic, but every country in the world – no matter rich or poor – has much more to do to make it happen. Learn why. https://gilead.inc/4dnAoG9
-
We’re happy to share that Deborah Telman, EVP, Corporate Affairs and General Counsel, received the Legislative Award from The Black Women's Agenda (BWA). Founded in 1979, BWA is devoted to advancing, securing and protecting the rights of women by working collaboratively with 43 national and international women’s organizations. Deb received the honor in recognition of the initiatives she’s led at Gilead and beyond to make a difference in global communities, including Black women and their families. With more than 25 years of executive leadership experience, Deb has built a career grounded in service and continues to be a champion for health equity. Past Legislative Award recipients include Dr. Maya Angelou, Secretary Condoleezza Rice, The Honorable Kamala Harris and Dr. Johnnetta Cole.
-
Extraordinary progress toward ending the #HIV epidemic can be possible when leaders from around the world work together. That was the theme of a UNAIDS panel at the 79th United Nations General Assembly where Daniel O'Day, Gilead Chairman and Chief Executive Officer, took to the stage. Dan shared the company’s longstanding efforts to transform the treatment and prevention landscape for HIV and its ongoing work to ensure its medications translate to impact for populations around the world. “Through scientific innovation, collaboration and putting people at the center, we will do everything possible to make our shared goal of ending AIDS a reality,” he said. The Global Fund #UNGA79
-
Reflecting on #ESMO24 and #WCLC24, Gilead’s Amy Otto shared her perspective on how these gatherings foster collaboration and creativity, helping us write the next chapters to transform the way cancer is treated. Read more: https://gilead.inc/3MTNccr
Pagine affiliate
Pagine simili
Sfoglia le offerte di lavoro
Azioni
GILD
NASDAQ
Ritardo di 20 minuti
84,95 USD
0,28 (0,331%)
- Apertura
- 84,86
- Minimo
- 84,165
- Massimo
- 84,975
Dati da Refinitiv
Vedi altre informazioni suRaccolta fondi
Ultimo round
Capitale post-IPO210.000.000,00 USD
Investitori
Abingworth